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This paper focuses on reviewing the roles of optical coherence tomography (OCT) on corneal surface laser ablation procedures.
OCT is an optical imaging modality that uses low-coherence interferometry to provide noninvasive cross-sectional imaging
of tissue microstructure in vivo. There are two types of OCTs, each with transverse and axial spatial resolutions of a few
micrometers: the time-domain and the fourier-domain OCTs. Both have been increasingly used by refractive surgeons and have
specific advantages. Which of the current imaging instruments is a better choice depends on the specific application. In laser
in situ keratomileusis (LASIK) and in excimer laser phototherapeutic keratectomy (PTK), OCT can be used to assess corneal
characteristics and guide treatment decisions. OCT accurately measures central corneal thickness, evaluates the regularity of
LASIK flaps, and quantifies flap and residual stromal bed thickness. When evaluating the ablation depth accuracy by subtracting
preoperative from postoperative measurements, OCT pachymetry correlates well with laser ablation settings. In addition, OCT
can be used to provide precise information on the morphology and depth of corneal pathologic abnormalities, such as corneal
degenerations, dystrophies, and opacities, correlating with histopathologic findings.
1. Introduction
Optical coherence tomography (OCT) is an optical imaging
modality that performs noninvasive cross-sectional imag-
ing of tissue microstructure in vivo [1]. It uses low-
coherence interferometry to measure the delay and inten-
sity of backscattered infrared light reflected from tissue
structures [1]. The measurement is based on comparing
the backscattering of tissue to light that travels a known
reference path with a reference mirror [1]. To obtain an OCT
image, the device creates a series of axial scans (A scans)
and combines these scans to form a composite image [1].
OCT has transverse and axial spatial resolutions of a few
micrometers and can detect reflected signals as small as 10−10
of the incident optical power [1].
Anterior segment OCT (AS-OCT) utilizes a superlumi-
nescent diode with a wavelength of approximately 1310 nm
to produce high-resolution images of the anterior segment of
the eye [2], achieving a 10- to 25-fold better resolution than
high-frequency ultrasound imaging [3]. In refractive surgery,
this device has been increasingly used in various clinical
situations, such as central corneal thickness (CCT) measure-
ment, preenhancement evaluation of flap and stromal bed
thickness, and morphologic and depth assessment of corneal
pathologic abnormalities. The purpose of this paper is to
review the role of AS-OCT on corneal surface laser ablation
procedures, focusing on the diﬀerent devices available and
their main clinical applications.
2. AS-OCT Devices
Two AS-OCT devices that are commercially available are the
Visante OCT (Carl Zeiss Meditec, Dublin, USA) and the
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Slit-lamp OCT (Heidelberg Engineering GmbH, Heidelberg,
Germany). Both are time-domain OCTs; while producing
their A-scans, the reference mirror subsequently changes in
position to produce a reflectivity profile corresponding to
depth. Therefore, the speed of these systems depends on the
mechanical cycle time of the reference mirror driver [4],
which limit the 3-dimensional (3-D) imaging of the ocular
tissue. The Visante OCT has a transverse resolution of 60 µm
and an axial resolution of 18 µm, while the Slit-lamp OCT
has a transverse resolution of 75 µmand an axial resolution of
25 µm [5]. Both devices yield up to 2048 A scans per second
[6].
Diﬀerently, fourier-domain (or spectral-domain) OCT
has a stationary reference mirror and utilizes a spectrometer
to detect the interference between the sample and reference
reflections. Thus, image acquisition is faster than with time-
domain OCTs [7], enabling 3-D imaging of the anterior
segment [8]. The RTVueOCT (Optovue Inc., Fremont, USA)
and the Cirrus OCT (Carl Zeiss Meditec, Dublin, USA)
are fourier-domain OCTs that use light with a wavelength
of approximately 830 nm. They were both initially devel-
oped to create images of the posterior segment. However,
adjustments can be made to analyze the anterior segment.
They have an axial resolution of 5 µm and a transverse
resolution of 15 µm [7, 9]. The Casia SS-1000 OCT (Tomey
Corporation, Nagoya, Japan) is a commercially available
anterior segment fourier-domain OCT. As all AS-OCTs, it
operates at a 1310-nm wavelength, having an axial and
a transverse resolution of approximately 10 and 20 µm,
respectively [8, 10]. When comparing fourier-domain and
time-domain OCT, the former achieves a higher resolution
of smaller areas, allowing visualization of more tissue details,
while the latter shows all anterior segment structures in a
single image, which is sometimes essential in clinical practice
[6, 11].
3. Role of OCT on Laser In Situ
Keratomileusis (LASIK)
Laser in situ keratomileusis (LASIK) is an increasingly more
common keratorefractive surgery worldwide. CCT is impor-
tant for pretreatment screening and surgical planning [12].
AS-OCT can be used to evaluate this thickness. Previous
studies have compared the OCT CCT measurement with the
ultrasound pachymetry, which is the standard device used
for measuring CCT. A strong correlation is seen between
the CCT measurements with these two devices [12–15].
However, results vary regarding the diﬀerence in OCT and
ultrasound pachymetry. While Kim et al. [13] have found no
statistically significant diﬀerence between the measurements,
other studies [12, 14–17] reported that the OCT pachymetry
was systematically lower than the ultrasound pachymetry.
It is unclear whether ultrasound or OCT measurements
reflect more accurately the true corneal thickness. However,
the repeatability of each device supports their application
in CCT measurement although they should not be used
interchangeably, and the CCT value should be interpreted in
the context of the instrument applied [12, 14–17].
The preparation of the LASIK flap, which can be done
with a microkeratome or a femtosecond laser, is the first
critical step of the surgery [18]. In the past, the flap was
evaluated exclusively by the central flap thickness [19]. This
is still an important parameter for the safety of a LASIK
procedure [20]. However, studies have shown the importance
of analyzing the entire flap’s morphology; although the
basic diﬀerences in flap morphology regularity between
femtosecond laser flaps and microkeratome flaps are in the
periphery, the femtosecond laser flaps introduce significantly
less lower-order and higher-order optical aberrations and
lead to better visual acuity results [18, 21, 22].
The Visante OCT and a similar prototype have been used
to assess the accuracy of the entire flap thickness and the flap
morphology created by a femtosecond laser and a microker-
atome [18, 23–25]. The repeatability analysis showed that
the OCT flap thickness measurement was reliable for the
entire extension of the flap [18, 23, 25]. The RTVue OCT
also provides highly repeatable flap thickness measurements
[9]. However, when comparing this device with the Visante
OCT, the former is 13 times faster and produces an image
with 3 times more resolution [11]. This resulted in a closer
agreement in measurements between observers and between
instruments and provided more consistent estimates of post-
LASIK flap thickness [11]. Nevertheless, the RTVue OCT
has the disadvantage of imaging a small tissue range, not
scanning the angle recess or iris root [11]. Thus, each OCT
design has distinct advantages, and which of the current
imaging instruments is a better choice that depends on the
application [4].
OCT devices best detect LASIK flaps in the corneal
pericentral zone (2–5mm in diameter), where the stromal
bed signal is low, contrasting with the higher flap internal
reflectivity and the flap interface peak [23]. Near the corneal
vertex (<2mm in diameter) the contrast is poor, because
the interface reflections are overwhelming and both flap
and bed internal reflectivities are high [23]. The higher
resolution of the RTVue OCT enables flap measurements
taken at 0.0mm to be more reproducible than with the
Visante system [11]. In myopic retreatments, the thinnest
point is in the corneal center, making it the most important
location for obtaining accurate thickness measurements for
planning a subsequent surgery [11]. The increased flap
internal reflectivity diminishes with time, but is present for
at least 1 year after LASIK [24].
In addition to measuring flap thickness, OCT eﬀectively
assesses stromal bed thickness, which is an important
measurement before an enhancement procedure [23, 24, 26–
28]. A residual stromal bed thickness of less than 250 µm
post-LASIK is one of the main risk factors for keratectasia: a
rare, but serious LASIK complication, characterized by pro-
gressive corneal distortion caused by weakening of corneal
structure [20]. Although the current gold standard for
assessing flap and stromal bed thickness is the intraoperative
ultrasound subtraction pachymetry [24, 26], it has some
disadvantages that led to the investigation of alternate
methods for these measurements, such as the OCT. The
intraoperative ultrasound flap pachymetry measurement
is attained by subtracting the intraoperative stromal bed
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thickness from the preoperative corneal thickness, whereas
the OCT determines this measurement by assessing the
distance from the corneal surface to the flap interface [26].
In addition, there is room for OCT in identifying post-LASIK
corneal ectasia in corneas with normal preoperative parame-
ters, associated with a thicker than expected LASIK flap. Also,
theremay be other, as yet unidentified, risk factors for ectasia.
Possible causes may include changes in preoperative corneal
biomechanical properties or tomographic parameters and
their correlation to alterations secondary to the cutting of a
LASIK flap.
The Artemis 3-D very-high-frequency (VHF) digital
ultrasound device (ArcScan Inc., Morrison, USA) is an
option for evaluating the flap and residual stromal thickness.
It has a LASIK flap thickness reproducibility of 1.14 µm [29],
which is better than the repeatability of the Visante OCT
(4.5–17.6 µm) [13, 24] and the RTVue system (4.19–4.9 µm)
[11]. Nevertheless, measurements with the Artemis device
require direct ocular contact. Diﬀerently, OCT is a more
practical technology because it is a noncontact method and
has the benefit of providing high-resolution flap imaging
over a wide area [12].
In LASIK surgeries in which a femtosecond laser was
used to create a flap, intraoperative ultrasound flap thick-
ness measurements were similar to postoperative Visante
OCT pachymetry [23, 24]. However, when a Hansatome
microkeratome (Bausch & Lomb Surgical, Rochester, USA)
was used, ultrasound measurements were thinner than
OCT measurements [23, 24, 26]. The factors that explain
this diﬀerence are not yet well understood. In one of
the studies the authors [23] hypothesized that the flap
hydration justified this finding. In this study, the OCT flap
measurements were obtained 1 week after LASIK in all cases.
The ultrasound stromal bed measurements were made 1
hour after the femtosecond laser cut and immediately after
the microkeratome cut [23]. The authors believe that the real
flap thickness was the one measured in the microkeratome
group by the intraoperative ultrasound and that there was
a hydration shift by the time the flap was measured 1
hour after its creation in the femtosecond group and 1
week postoperatively in both groups, resulting in thicker
measurements [23]. However, this could not explain the
findings of Murakami and Manche [24], as their OCT flap
measurements were obtained 1 year after LASIK in all cases,
when the edema had resolved [30]. Figure 1 is illustrative of
flap thickness image with OCT.
A previous study [27] compared intraoperative
ultrasound pachymetry with postoperative RTVue flap
measurement in surgeries that used the Amadeus II
microkeratome (Ziemer Ophthalmic Systems AG, Port,
Switzerland) and Med-Logics blades (ML7090CLB; Med-
Logics Inc., Laguna Hills, USA) to create all flaps. Both
pachymetry devices attained equivalent measurements [27].
The OCT pachymetry was done 2 weeks after the procedure.
This study did not include a group of patients in which
the flap was created with a femtosecond laser. Possible
explanations for these diﬀerent findings when comparing
to the aforementioned microkeratome results are the use of
a fourier-domain OCT device in the later study [11], the
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Figure 1: Optical coherence tomography showing a postoperative
flap thickness of 177 µm, producing a residual stromal bed of
274 µm in the right eye. Data would help in case of an enhancement
is needed.
diﬀerent microkeratomes used [31], and the variability in
postoperative time of OCT flap measurement [30]. Further
studies are necessary to clarify these diﬀerences in OCT and
ultrasound flap measurements to determine which is the
most accurate method for flap thickness assessment.
Nevertheless, when evaluating the ablation depth accu-
racy by subtracting preoperative from postoperative mea-
surements, OCT pachymetry agreed better with the laser
ablation settings than the ultrasound pachymetry [12].
The OCT provides an assurance before an enhancement
procedure that suﬃcient stromal bed thickness is present,
instead of detecting the insuﬃcient bed thickness after lifting
the flap and performing an ultrasound measurement during
the procedure [12]. Furthermore, comparisons between
the 1-week postoperative and the preenhancement OCT
measurements could reveal any thickness change that may
be associated with keratectasia [12], contraindicating an
additional LASIK procedure.
In the postoperative period, OCT enables identification
of unexpected corneal changes, such as epithelial ingrowth
[32]. OCT is also useful in assessing the recurrence of corneal
dystrophy deposits after LASIK. The flap thickness and the
location and the extent of the newly formed deposits are
essential for determining the best treatment option [33].
4. Role of OCT in Excimer Laser
Phototherapeutic Keratectomy (PTK)
Excimer laser phototherapeutic keratectomy (PTK) is a
treatment option for anterior corneal disorders that signifi-
cantly degrade visual acuity. Three categories of conditions
that are candidates for PTK are anterior corneal scars
and opacities, elevated corneal lesions, and dystrophies of
the epithelium, Bowman’s membrane, and anterior corneal
stroma. Although PTK can be used to treat disorders that
aﬀect the anterior one-third of the cornea, it is best suited
for disorders in the anterior 10–20% of the corneal stroma.
No more than one-third of the corneal thickness should be
removed, and at least 250 µm of stroma should remain after
surgery [34]. Thus, an exam capable of producing precise
corneal images independently of corneal transparency is
necessary for screening possible candidates. OCT accurately
maps corneal thickness in clear and opacified corneas,
allowing the examiner to precisely map the depth of corneal
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Figure 2: Optical coherence tomography showing corneal scar. The
image is helpful in case photorefractive keratectomy is considered.
abnormalities and plan the procedure [4, 33, 35, 36]. Figure 2
is illustrative of corneal scar image with OCT.
In cases with corneal scars and opacities, the Cirrus OCT
has been shown to accurately measure corneal thickness
and map the depth of these corneal abnormalities [32]. A
previous paper compared the pachymetry of corneas with
opacities measured with a high-speed anterior segment OCT
prototype (Carl Zeiss Meditec, Dublin, USA), similar to the
Visante OCT, an ultrasound pachymetry and an Orbscan
II (Bausch & Lomb Inc., Rochester, USA) [37]. The OCT
accurately measured corneal thickness and depth of corneal
opacity, having similar results to the ultrasound pachymetry.
Although the Orbscan II also provided pachymetric map-
ping, it significantly underestimated corneal thickness. Thus,
OCT and ultrasound pachymetry are better imaging exams
to assess corneal thickness in eyes with corneal opacities
and to measure opacity depth for selecting and planning the
appropriate treatment procedure [37].
Salzmann’s nodular degeneration and keratoconus nod-
ules are elevated corneal lesions [38, 39]. OCT can be used
to assess the morphology of these nodules [40, 41]. Many
of the established histopathologic findings can be seen using
the Visante OCT in vivo [41]. In addition, OCT determines
the nodule’s depth, which will help define the best treatment
strategy for each case [42].
Time-domain OCTs can also be used to assess eyes with
corneal dystrophies and guide treatment decisions [6, 43].
Similarly to cases with Salzmann’s nodules, in cases of
corneal dystrophies the pattern of corneal deposits on the
cross-sectional time-domain OCT scans correspond to that
on histopathologic serial sections [36]. However, the higher
resolution of fourier-domain OCTs allows visualization of
even more details [6]. The Cirrus OCT can accurately
map corneal dystrophies [32]. It has been shown that the
RTVue device enables the visualization of corneal guttae
on the posterior corneal surface of eyes with Fuchs corneal
dystrophy, irregularity of Bowman layer in eyes with macular
dystrophy, lattice lines in eyes with lattice corneal dystrophy,
and morphology and depth of the deposits in eyes with
granular corneal dystrophy type 2 [6, 44]. It also allows
visualization of subepithelial fluid in eyes with bullous
keratopathy [6].
Before introducing fourier-domain OCT, the corneal
surface was ablated to some degree, and the remaining
corneal opacity was examined using the slit lamp in the
sitting position. The corneal ablation and slit lamp exami-
nation were repeated until vision-threatening deposits were
removed [33]. Diﬀerently, some authors have shown that the
actual required PTK ablation depth correlates well with the
depth predicted by a fourier-domain OCT [45]. However,
even though the fourier-domain OCT has a better resolution
than the time-domain devices, in clinical practice it is
sometimes essential to assess all anterior segment structures
in a single image [6]. Thus, the choice of the device used in
each case is based on the reason that led to the exam [4].
5. Conclusion
In the context of corneal surface laser ablation procedures,
the time-domain and fourier-domain OCTs can be used.
Both OCT designs have distinct advantages, and the better
choice depends on the needs of each particular case. OCT
can be used to accurately measure CCT, to evaluate the
regularity of LASIK flaps, to quantify flap and residual
stromal bed thickness, and to evaluate post-LASIK com-
plications. Furthermore, it provides precise information on
the corneal structure, and on the morphology and depth of
corneal pathologic abnormalities, which help define the best
treatment strategy for each patient.
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